Medication for newborn reflux remains controversial in 2026, with recent NICU data showing that while 50% of infants receive pharmacologic intervention, only 15-20% truly require
GLP-1 receptor agonists represent a transformative class of prescription medications approved for type 2 diabetes management and, in select cases, weight management. As of 2026,
Lactose intolerance affects 70% of the global population, yet effective medication exists to restore dairy tolerance. Enzyme replacement therapies, prescription digestive aids, and emerging biologics
Trustpilot